We will provide an introduction to blood cancers including risk factors, epidemiology, presenting symptoms, g
|
Course DescriptionKaitlin Morrison, PhD takes you through the business principles of critical paths, PERT charts and Gantt charts and how they can be us
|
In working to address Native American cancer health disparities, it is imperative to build partnerships with tribal communities to increase their trust in the potential benefits of cancer research efforts. The Partnership for Native American Cancer Prevention was established in 2002 and the Partnership’s approach is to expand capacity for culturally-sensitive and community-relevant research on cancer and to continue to develop respectful collaborations that empower sovereign Native American communities to define, implement, and achieve their goals for cancer health equity.
|
Linda Burhansstipanov, MSPH, DRPH, OPN-CG provides an overview of how the field of patient navigation has evolved since its inception in the late 1980s / early 1990s. It includes a brief overview of the nationally recommended metrics and CMS codes for reimbursement of navigation services. It also identifies what is missing in the codes to fully address the cancer continuum.
|
Melissa Jim, MPH will describe our IHS linkage and characterize patterns of cancer incidence among AI/AN by IHS Region. We will discuss sources of AI/AN cancer data. I will also explore the United States Cancer Statistics: Data Visualizations website to show how to find AI/AN cancer data by IHS Region. Accurate cancer data is crucial to develop public health strategies and programs to address cancer disparities.
|
Embracing Indigenous Wisdom in Evidence Based Cancer Prevention: A Path of Collaboration, Respect, and Insight on Duke’s Voyage” is a presentation that explores the partnership between modern scientific research and indigenous wisdom in the pursuit of effective cancer prevention strategies. It underscores the humility in learning from indigenous knowledge, and the discovery of insights that can enhance evidence-based approaches to cancer prevention.
|
Cancer patients and survivors have higher rates of anxiety and depression compared to the general population. Cancer-related anxiety and depression may significantly reduce wellbeing and result in adverse treatment and survival outcomes. This lecture will provide an overview of psychotherapeutic modalities that can treat cancer-related distress.
|
Joe Polich, MSW, LCSWA, JD will provide a foundational knowledge to providers who come in contact with patients with cancer who are also experiencing IPV. Beginning with a quick introduction to some basic concepts of the dynamics of IPV in general, we will discuss the intersection of the provision of care to a patient with cancer and the dynamics involved in IPV.
|
Yuri Fedoriw, MD, provides a general background of cancer pathology and tissue diagnosis. The development of testing methods and their application will be discussed, as will the limitations and challenges of cancer classification.
|
Zev Nakamura, MD will present on key topics related to cognitive issues experienced by patients with cancer.
|